外周细胞因子水平与抑郁症抗抑郁治疗反应:系统综述与荟萃分析
该系统综述与荟萃分析纳入44项研究,探讨基线外周细胞因子水平及治疗前后变化与重性抑郁障碍抗抑郁治疗反应的关系。结果发现治疗应答者基线IL-8水平较低,且仅应答者治疗后TNF-α水平显著下降,应答者TNF-α下降幅度大于非应答者。提示外周细胞因子变化与抗抑郁治疗结局相关。
要点
- 基线IL-8较低与抗抑郁治疗应答相关(Hedge's g=-0.28)。
- 仅应答者抗抑郁治疗后TNF-α水平显著下降(Hedge's g=0.60)。
- 应答者TNF-α下降幅度显著大于非应答者(P=0.046)。
核心结论
- 外周细胞因子水平变化与MDD患者抗抑郁治疗结局相关。
- 基线IL-8较低及治疗后TNF-α下降可能提示治疗应答。
研究设计与样本
- 系统检索PubMed、Embase和Web of Science数据库,截至2018年10月,共纳入44项研究。
- 纳入报告MDD患者抗抑郁治疗前后基于验证抑郁量表评估的细胞因子水平的病例对照或病例-病例研究。
- 采用随机效应荟萃分析,评估各细胞因子的标准化均数差。
主要发现
- 抗抑郁治疗应答者基线IL-8水平低于非应答者(Hedge's g=-0.28;95%CI,-0.43至-0.13;P=0.0003;FDR=0.004)。
- 抗抑郁治疗仅在接受应答者中显著降低TNF-α水平(Hedge's g=0.60;95%CI,0.26-0.94;P=0.0006;FDR=0.004)。
- 应答者TNF-α水平下降显著多于非应答者(P=0.046)。
关键数值与推荐
- 基线IL-8较低与治疗应答相关:Hedge's g=-0.28;95%CI,-0.43至-0.13;P=0.0003;FDR=0.004。
- 应答者治疗后TNF-α下降:Hedge's g=0.60;95%CI,0.26-0.94;P=0.0006;FDR=0.004。
- 应答者与非应答者TNF-α下降差异:P=0.046。
临床怎么用
- 基线IL-8和治疗后TNF-α变化可能作为抗抑郁治疗反应的潜在预测标记,但需进一步验证。
局限性
- 需进一步研究阐明异质性来源,并验证炎症细胞因子作为MDD药物治疗新型预测标记的潜力。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Predicting antidepressant treatment response has been a clinical challenge for major depressive disorder (MDD). The inflammation hypothesis of depression suggests that cytokines play a key role in the pathophysiology of MDD and alterations in peripheral cytokine levels are associated with antidepressant treatment outcome. Present meta-analysis aimed to examine the association between baseline peripheral cytokine levels and the response to antidepressant treatment and to evaluate whether changes of cytokine levels were associated with the response to antidepressant treatment in patients with MDD. Human-based studies published in any language in peer-reviewed journals were systematically searched from the PubMed, Embase and Web of Science databases, from inception up to October 2018. The search terms included cytokine, depressive disorder and antidepressant and their synonyms. Case-control or case-case studies reporting on levels of IL-1β, IL-2, IL-4, IL-5, IL-6, IL-8, IL-10, IL-12, CRP, TNF-α, IFN-γ, GM-CSF, MIP-1α, and Eotaxin-1 in patients with MDD based on validated depression scales both before and after antidepressant treatment were included. Of 7408 identified records, 44 studies met inclusion. Standardized mean differences in each cytokine were evaluated, and random-effects meta-analyses were performed. MDD patients who responded to antidepressant treatment had lower baseline IL-8 levels than the nonresponders (Hedge's g = -0.28; 95%CI, -0.43 to -0.13; P = 0.0003; FDR = 0.004). Antidepressant treatment significantly decreased levels of TNF-α (Hedge's g = 0.60; 95%CI, 0.26-0.94; P = 0.0006; FDR = 0.004) only in responders, and responders showed significantly more decreased TNF-α levels compared with nonresponders (P = 0.046). These findings suggested that alterations in peripheral cytokine levels were associated with antidepressant treatment outcomes in MDD. Further investigations are warranted to elucidate sources of heterogeneity and examine the potentiality of using inflammatory cytokines as novel predictive markers for the pharmacological treatment of MDD.
引用
- Liu JJ, Wei YB, Strawbridge R, et al. Peripheral cytokine levels and response to antidepressant treatment in depression: a systematic review and meta-analysis. Mol Psychiatry. 2019. PMID: 31427752. doi:10.1038/s41380-019-0474-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。